Fractal analysis of beta-cyclodextrin-indomethacin particles compacted by ultrasound.
An association between indomethacin and beta-cyclodextrin (beta-CD) was obtained by compacting a 1:2 molar physical mixture by ultrasound. The product prepared by this technique was compared with the initial physical mixture and with materials having the same composition but prepared by a simple compaction and kneading process. The samples examined by scanning electron microscopy revealed morphological differences related to the methods of preparation. In particular the material obtained by ultrasound had a smooth surface and on milling produced particles of uniform size; moreover EDAX analysis (energy dispersion analysis by X-rays) also revealed a homogeneous distribution of the two components in each particle examined. Surface fractal dimension of the surface of these particles is very low, suggesting the presence of a regular and smooth surface whereas the sample obtained by kneading had a higher value. The reactive dimension related to dissolution was much higher than the corresponding surface dimension in all cases and had comparable values for all samples regardless of the techniques used. This behavior was attributed to the hydrophilicity of beta-CD, which levels the differences during dissolution and which could be originated by surface imperfections. Experimental results suggested that the material obtained by ultrasound had a dissolution rate comparable to that measured with the kneaded material. The use of ultrasound, however, can both reduce the production time and improve the homogeneity of the association between indomethacin and beta-CD.
Fini
A
A
Istituto di Scienze Chimiche, Università di Bologna, Italy.
Fernàndez-Hervàs
M J
MJ
Holgado
M A
MA
Rodriguez
L
L
Cavallari
C
C
Passerini
N
N
Caputo
O
O
D003505:Cyclodextrins / Q000737:chemistry*; D004577:Electron Probe Microanalysis; D017709:Fractals; D007213:Indomethacin / Q000737:chemistry*; D008855:Microscopy, Electron, Scanning; D012995:Solubility; D014465:Ultrasonics; D047392:beta-Cyclodextrins
D003505:Cyclodextrins; D047392:beta-Cyclodextrins; C031215:betadex; D007213:Indomethacin